Rivulet Media Inc (fka RIVU)

[Krisandtilly]

Regen had been previously notified by the FDA that it had cleared the clinical trial design, scientific rational and manufacturing components of its IND application.

This is not the fault of bmsn

all other cell base drugs that are being developed by other companies has the same steps to take bmsn is no different.

What's positive is that FDA will guide the process thus ensuring what is needed by them (IMO They will go to FAST TRACT")

Regen will do so .. By leveraging the experience of the FDA and their cell therapy experts,